Feature | February 06, 2014

Photon-Counting Technique Increases Detection Rate in Screening Mammography

Mammography Systems Women's Health Clinical Study DR CR Radiation Dose

This shows two-view screening mammograms obtained with the DR photon-counting system show a spiculated mass in the right upper quadrants (arrow). The diagnosis was invasive ductal carcinoma, 8 mm in diameter, as seen on the (a) right craniocaudal image, (b) right mediolateral oblique image, and (c) zoomed in craniocaudal image of the lesion.

Mammography Systems Women's Health Clinical Study DR CR Radiation Dose

Two-view screening mammograms obtained with the DR photoncounting system show an indistinct mass in the left lower outer quadrant (arrow). The diagnosis was invasive ductal carcinoma, 7 mm in diameter, as seen on the (a) left craniocaudal image, (b) left mediolateral oblique image, and (c) zoomed in craniocaudal image of the lesion.

Mammography Systems Women's Health Clinical Study DR CR Radiation Dose

Two-view screening mammograms obtained with the DR photoncounting system show pleomorphic calcifications in a linear distribution in the right upper quadrants (arrow). The diagnosis was DCIS, as depicted on the (a) right craniocaudal image, (b) right mediolateral oblique image, and (c) zoomed in craniocaudal image of the lesion.

February 6, 2014 — Digital mammography screening with photon-counting technique offers high diagnostic performance, according to a study published online in the journal Radiology.
 
As mammography screening has shifted to digital technology, a range of computed radiography (CR) and direct radiography (DR) systems have emerged. The photon-counting technique is a DR approach that uses a detector to decrease scattered radiation and noise, enabling dose reduction.
 
"In population-based mammography screening, dose reducing techniques that don't compromise outcome parameters are desirable," said Walter Heindel, M.D., department of clinical radiology at the University Hospital Muenster in Muenster, Germany.
 
For the study, Heindel and colleagues analyzed data from the mammography screening program in North Rhine-Westphalia, the most populous state in Germany. They compared the screening performance of a DR photon-counting scan system with those of statewide operating screening units using different digital technologies. During the study period (2009 to 2010), 13,312 women were examined using the photon-counting system, and 993,822 women were screened with either CR or DR systems alone.
 
The DR photon-counting scan system had a cancer detection rate of 0.76 percent for subsequent screening, compared with 0.59 percent for the other screening units. The recall rate was 5.4 percent for the photon-counting method and 3.4 percent for the other methods.
 
"The higher cancer detection resulting from the use of the DR photon-counting scan system is due to high detection of both small, invasive cancers and ductal carcinoma in situ," Heindel said.
 
The photon-counting technique had almost twice the detection rate of other methods for ductal carcinoma in situ (DCIS), an early, noninvasive form of disease. It had a higher DCIS detection rate than the statewide units and the conventional DR subgroup.
 
In addition, the mean average glandular radiation dose of the DR photon-counting scan system was significantly lower than the conventional DR systems with the individually used parameters of the automatic exposure control.
 
The photon-counting technique also offers lateral dose modulation during the image acquisition, which can help account for differences in breast density. 
 
"One future research direction is the application of spectral imaging for quantification of breast glandular tissue, addressing the problem of breast density," Heindel said.
 
For more information: pubs.rsna.org/journal/radiology

Related Content

Technology | Computer-Aided Detection Software | December 07, 2016
QView Medical Inc. announced that it received U.S. Food and Drug Administration (FDA) approval in early November for...
Ikonopedia, Closed-Loop Resolution Manager, breast imaging, reporting, RSNA 2016
News | Breast Imaging | December 07, 2016
Ikonopedia showcased its new Closed-Loop Resolution Manager, designed to keep breast imaging patients from falling...
PET, F-18 florbetaben, cardiac amyloidosis, Princess Alexandria Hospital

In a pilot study, F-18-florbetaben PET imaging appeared promising for differentiating between cardiac amyloidosis and hypertensive heart disease. Image courtesy of W. Phillip Law/Princess Alexandra Hospital, Brisbane, Australia. 

News | Nuclear Imaging | December 06, 2016
Researchers at Princess Alexandra Hospital, Brisbane, Australia, have demonstrated that cardiac amyloidosis (abnormal...
astronauts, MRI study, visual impairment, RSNA 2016

Image courtesy of NASA

News | Magnetic Resonance Imaging (MRI) | December 02, 2016
A visual problem affecting astronauts who serve on lengthy missions in space is related to volume changes in the clear...
tomosynthesis, early detection, breast cancer, Solis Mammography, Stephen Rose, RSNA 2016
News | Breast Imaging | December 02, 2016
New research presented at the 2016 Radiological Society of North America (RSNA) annual meeting found recall rates,...
Volpara Solutions, VolparaEnterprise 2.0, breast imaging software, RSNA 2016
News | Breast Imaging | December 02, 2016
Volpara Solutions announced the launch of VolparaEnterprise 2.0 software, which helps breast imaging providers deliver...
coronary CT angiography, CCTA, CAD, coronary artery disease, alcohol consumption, RSNA 2016
News | CT Angiography (CTA) | November 29, 2016
Researchers using coronary computed tomography angiography (CCTA) found no association between light to moderate...
mammography, age cut-off, clinical study, RSNA 2016, Cindy Lee
News | Mammography | November 28, 2016
In the largest-ever study on screening mammography outcomes, researchers found that there is no clear cut-off age to...
Dilon Diagnostics, GE Healthcare, RSNA 2016, Discovery NM750b molecular breast imaging system, biopsy accessory, FDA clearance
Technology | Breast Imaging | November 28, 2016
November 28, 2016 — Dilon Diagnostics and GE Healthcare announced the U.S.
Overlay Init